Overview

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Study Status: Duke University Health System Institutional Review Board has received notification of study termination; final IRB closure date is 12/12/2008. Study enrollment is now closed. Enrollment Update: Only one subject was entered into this study out of an expected enrollment of 15 patients in this single site clinical trial. With no recruitment interest, the financial sponsor and Sponsor-PI chose to close the clinical trial.
Phase:
Phase 4
Details
Lead Sponsor:
John Murray
Collaborator:
Astellas Pharma US, Inc.
Treatments:
Alefacept